[go: up one dir, main page]

CN108125803A - A kind of whitening spot-eliminating composition - Google Patents

A kind of whitening spot-eliminating composition Download PDF

Info

Publication number
CN108125803A
CN108125803A CN201810123967.7A CN201810123967A CN108125803A CN 108125803 A CN108125803 A CN 108125803A CN 201810123967 A CN201810123967 A CN 201810123967A CN 108125803 A CN108125803 A CN 108125803A
Authority
CN
China
Prior art keywords
water
soluble
whitening
oil
freckle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201810123967.7A
Other languages
Chinese (zh)
Other versions
CN108125803B (en
Inventor
王春儒
李慧
李岩淞
陈相龙
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing Rensheng Zefa Biotechnology Co ltd
Chifeng Renze Cosmetics Co ltd
Suzhou Rensheng Zefa Biotechnology Co ltd
Original Assignee
Beijing Fullcan Biotechnology Co ltd
Institute of Chemistry CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Fullcan Biotechnology Co ltd, Institute of Chemistry CAS filed Critical Beijing Fullcan Biotechnology Co ltd
Priority to CN201810123967.7A priority Critical patent/CN108125803B/en
Publication of CN108125803A publication Critical patent/CN108125803A/en
Application granted granted Critical
Publication of CN108125803B publication Critical patent/CN108125803B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31Hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/342Alcohols having more than seven atoms in an unbroken chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41Amines
    • A61K8/416Quaternary ammonium compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/602Glycosides, e.g. rutin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63Steroids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86Polyethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/891Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/524Preservatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

本发明公开了一种美白祛斑组合物,包括下述重量百分比的原料制成:富勒烯0.1‑1.2%、乳化剂1‑5%、皮肤调理剂3‑9%、保湿剂1‑20%,余量水,该组合物可彻底解决斑点问题,修复细胞的抗损伤能力,从根本上解决长斑问题,治愈不复发,尤其是炎症所致的色素沉着。

The invention discloses a whitening and freckle-removing composition, which is made of the following raw materials in percentage by weight: 0.1-1.2% of fullerene, 1-5% of emulsifier, 3-9% of skin conditioning agent, and 1-20% of moisturizing agent , the balance of water, the composition can completely solve the problem of spots, repair the anti-damage ability of cells, fundamentally solve the problem of long spots, and cure without recurrence, especially the pigmentation caused by inflammation.

Description

一种美白祛斑组合物Composition for whitening and removing freckles

技术领域technical field

本发明涉及美白祛斑领域,特别涉及含有富勒烯的美白祛斑组合物产品配方。The invention relates to the field of whitening and freckle removal, in particular to a product formula of a whitening and freckle removing composition containing fullerene.

背景技术Background technique

一直以来,美白祛斑都是人们所热切关注的话题。东方人希望通过美白护理品的使用而得到白皙、光洁的皮肤,而欧美消费者主要利用功能型美白化妆品来减轻老年斑、黄褐斑等色素沉积。随着生化科技的发展,人们对黑色素合成生物学机制的认识正不断深入,越来越多的科研工作者倾向于从天然植物中寻找安全高效的美白祛斑活性物质。For a long time, whitening and freckle removal has been a hot topic of concern. Orientals hope to obtain fair and smooth skin through the use of whitening care products, while European and American consumers mainly use functional whitening cosmetics to reduce pigmentation such as age spots and chloasma. With the development of biochemical technology, people's understanding of the biological mechanism of melanin synthesis is deepening, and more and more researchers tend to look for safe and efficient whitening and anti-freckle active substances from natural plants.

人类皮肤的颜色主要取决于黑色素的含量和分布,而黑色素细胞(melanocyte)的结构功能和数量直接影响皮肤中黑色素的含量,是产生黑色素的决定因素。黑色素细胞属腺细胞,其中有形成黑色素的膜性细胞器即黑色素小体(melanosome)。黑色素细胞具有树状突起,通过树状突起,与角质形成角化细胞(keratinocyte)构成一个表皮黑色素单位。在表皮黑色素单位中,黑色素细胞与角质形成细胞之间互相影响,尤其是角质形成细胞可通过接触及分泌碱性成纤维细胞生长因子(hFGF)、内皮素(ET-1)、神经细胞生长因子(NGF)、白介素1(I L-1)、白介素6(I L-6)、肿瘤坏死因子(TNF)等对黑色素细胞的形态、结构和功能产生明显的影响。黑色素细胞的树状突起实际为一管道,黑色素细胞内所产生的黑色素由此枝状管运输到角质形成细胞,一部分在角质形成细胞内被溶酶体降解,一部分随着细胞的新陈代谢而被带到角质层中,最后随角质化细胞脱落。但当黑色素过速增长和分布不均时,就会造成局部皮肤过黑和色素沉着。黑色素的合成必须有三种物质参与:①酪氨酸为制造黑色素的主要原料;②酪氨酸酶是酪氨酸转变为黑色素的主要限速酶;③酪氨酸在酪氨酸酶的作用下产生黑色素,此种作用为氧化过程,必须与氧结合才能转变为黑色素。黑色素细胞合成黑色素是一组相当复杂的过程,目前公认的黑色素合成途径为:酪氨酸——多巴——多巴醌——多巴色素——5,6-二羟基吲哚——5,6-吲哚醌——黑色素,合成的黑色素叫真黑色素,皮肤的色素主要由其组成。The color of human skin mainly depends on the content and distribution of melanin, and the structure, function and quantity of melanocytes directly affect the content of melanin in the skin, and are the decisive factors for the production of melanin. Melanocytes are glandular cells, which contain melanin-forming organelles called melanosomes. Melanocytes have dendritic processes through which they form an epidermal melanin unit with keratinocytes. In the epidermal melanin unit, melanocytes and keratinocytes interact with each other, especially keratinocytes can contact and secrete basic fibroblast growth factor (hFGF), endothelin (ET-1), nerve cell growth factor (NGF), interleukin 1 (IL-1), interleukin 6 (IL-6), tumor necrosis factor (TNF), etc. have obvious effects on the morphology, structure and function of melanocytes. The dendrites of melanocytes are actually a pipe, through which the melanin produced in melanocytes is transported to keratinocytes, part of which is degraded by lysosomes in keratinocytes, and part of which is carried along with the metabolism of the cells. into the stratum corneum, and finally shed with the keratinocytes. But when melanin grows too fast and distributes unevenly, it will cause local skin to be too dark and pigmentation. There must be three substances involved in the synthesis of melanin: ① tyrosine is the main raw material for producing melanin; ② tyrosinase is the main rate-limiting enzyme for the conversion of tyrosine into melanin; ③ tyrosine is activated by tyrosinase Melanin is produced, and this action is an oxidation process, which must be combined with oxygen to be converted into melanin. The synthesis of melanin in melanocytes is a set of quite complicated processes. The currently recognized melanin synthesis pathway is: tyrosine-dopa-dopaquinone-dopachrome-5,6-dihydroxyindole-5 , 6-indole quinone - melanin, the synthetic melanin is called eumelanin, and the pigment of the skin is mainly composed of it.

色斑是面部容易看到的黑色素沉着的代表,包括雀斑、老人斑、炎症后的色素沉着等。黑色素不一定全为黑色,根据黑色素化程度的不同,其颜色可为黄、红、褐、黑等颜色。人类皮肤及头发颜色不是取决于黑色素细胞的数量,而是取决于黑色素小体的数量、大小、分布及黑色素化程度。不同种族的人皮肤中黑色素细胞数大体上相同,但黑种人角朊细胞内的黑色素小体数量多、形态大、黑色素化程度深、单个散在分布、降解缓慢,而白种人角朊细胞内的黑色素小体数量少、形态小、黑色素化程度轻、多聚集分布于吞噬溶酶小体内,易降解。Pigmentation is a representative of melanin that is easy to see on the face, including freckles, age spots, post-inflammatory hyperpigmentation, etc. Melanin is not necessarily all black, depending on the degree of melaninization, its color can be yellow, red, brown, black and other colors. The color of human skin and hair depends not on the number of melanocytes, but on the number, size, distribution and degree of melaninization of melanosomes. The number of melanocytes in the skin of people of different races is basically the same, but the number of melanocytes in the keratinocytes of black people is large, the shape is large, the degree of melanization is deep, the distribution is single, and the degradation is slow, while the keratinocytes of white people The number of melanosomes is small, the shape is small, the degree of melanization is light, and they are more aggregated and distributed in phagolysosomes, which are easy to degrade.

近年来,不断有新的外用美白剂被迅速研发出来,其中最主要的作用机理是通过抑制酪氨酸酶而达到美白效果。针对酪氨酸酶的作用机制可分为抑制酪氨酸酶的活性、减少酪氨酸酶的产生和合成、抑制酪氨酸酶的糖化、加速酪氨酸酶的分解。此外,还有些美白剂可作用于黑色素形成的其它环节以及黑色素的转运代谢。按不同的作用机制,目前已开发的美白活性成分主要包括:抑制酪氨酸酶活性的成分,如曲酸及其衍生物、甘草黄酮、桑树提取物等;减少酪氨酸酶产生或合成的成分,如壬二酸、胎盘素、姜科植物lempuyang(Zinginer aromaticum)等;抑制酪氨酸酶的糖化作用,使得酪氨酸酶无法从内质网传送到黑色素小体内,具有此作用的活性成分如氨基葡糖、软骨糖氨、衣酶素等;加速酪氨酸酶分解的成分,如亚麻油酸及次亚麻油酸等;还原黑色素及抑制黑色素合成的成分,如维生素C及其衍生物、熊果苷等;抑制黑色素颗粒转移至角质形成细胞的成分,如烟酰胺、绿茶提取物、黄豆提取物、RWJ-50353、抑糖蛋白等;抑制内皮素与黑色素细胞受体结合的成分,如西洋甘菊Matricacia、德国洋甘菊等;软化角质层和加速角质层脱落(加速黑色素排出体外)的成分,如果酸等。此外,在美白化妆品中还会加入一些抵抗紫外线的成分,以减少紫外线、氧自由基等对黑色素形成生理过程的负面影响。但是,现有祛斑产品,祛斑功效并不明显,或者短时间内祛斑后又产生新斑点。In recent years, new topical whitening agents have been developed rapidly, and the main mechanism of action is to achieve whitening effect by inhibiting tyrosinase. The mechanism of action against tyrosinase can be divided into inhibiting the activity of tyrosinase, reducing the production and synthesis of tyrosinase, inhibiting the glycation of tyrosinase, and accelerating the decomposition of tyrosinase. In addition, some whitening agents can act on other links of melanin formation and the transport and metabolism of melanin. According to different mechanisms of action, the currently developed whitening active ingredients mainly include: ingredients that inhibit tyrosinase activity, such as kojic acid and its derivatives, licorice flavonoids, mulberry extract, etc.; ingredients that reduce the production or synthesis of tyrosinase Ingredients, such as azelaic acid, placenta, lempuyang (Zinginer aromaticum), etc.; inhibit the glycosylation of tyrosinase, so that tyrosinase cannot be transported from the endoplasmic reticulum to the melanin body, and has the activity of this effect Components such as glucosamine, cartilage glycosaminoglycans, elastin, etc.; components that accelerate the decomposition of tyrosinase, such as linoleic acid and sublinolenic acid, etc.; components that reduce melanin and inhibit melanin synthesis, such as vitamin C and its derivatives substances, arbutin, etc.; components that inhibit the transfer of melanin granules to keratinocytes, such as nicotinamide, green tea extract, soybean extract, RWJ-50353, glycostatin, etc.; components that inhibit the combination of endothelin and melanocyte receptors , such as Western chamomile Matricacia, German chamomile, etc.; ingredients that soften the cuticle and accelerate the exfoliation of the cuticle (accelerate the excretion of melanin), such as if acid. In addition, some anti-ultraviolet ingredients will be added to whitening cosmetics to reduce the negative effects of ultraviolet rays and oxygen free radicals on the physiological process of melanin formation. However, in the existing freckle-removing products, the freckle-removing effect is not obvious, or new spots are produced after freckle-removing in a short period of time.

富勒烯的多个P轨道构成的大π键共轭体系,使得其具有较强的接受电子的能力,因其独特的结构和理化性质,使其具有优异的清除自由基性能,被称为“自由基海绵”,同时还表现出了优异的抗氧化性能。使其在化妆品材料、生物医药等方面得到广泛关注。The large π-bonded conjugated system composed of multiple P orbitals of fullerene makes it have a strong ability to accept electrons. Because of its unique structure and physical and chemical properties, it has excellent free radical scavenging performance, known as The "free radical sponge" also exhibits excellent antioxidant properties. It has been widely concerned in cosmetic materials, biomedicine and other aspects.

通过将C60嵌入表面活性剂中,C60仍可以消除细胞内的活性氧,抑制线粒体的去极化、半胱氨酸蛋白酶的激活、细胞膜上磷脂酰丝氨酸的曝光以及DNA的分裂,C60表现出了保护细胞不被氧化凋亡的作用。C60脂质体复合物通过防御UVA对皮肤结构,细胞核和胶原纤维的破坏以及向人体皮肤组织的渗透来起到抗氧化作用,是维他命C的172倍,能够亲和自由基。By embedding C60 into surfactants, C60 can still eliminate reactive oxygen species in cells, inhibit mitochondrial depolarization, activation of cysteine proteases, exposure of phosphatidylserine on cell membranes, and DNA cleavage, and C60 exhibits Protect cells from oxidative apoptosis. C60 liposome complex plays an anti-oxidant role by defending against UVA damage to skin structure, cell nucleus and collagen fibers, and penetrating into human skin tissue. It is 172 times that of vitamin C and can affinity free radicals.

Fathi Moussa教授长期从事C60的性质研究工作,作为将富勒烯溶于橄榄油中进行研究的第一人,他们通过对老鼠10-17个月每两周喂一次(每公斤体重喂4毫克富勒烯),对照组老鼠17-38个月死亡,而试验组寿命则延长至59-66个月,发现富勒烯具有长寿保健功能。期间无论体重,生理表现无一异常,并未发现C60具有毒性和生物遗传性,相反一定量的C60具有清除自由基性能,从而使动物免受过多自由基产生的危害。专利2004800222529公开一种含有富勒烯簇的化妆品组合物,组合物中包含富勒烯簇及载体,用于防止或延迟皮肤中自由基氧化过程,该专利中的技术内容没有在皮肤表面形成保护层,只是对皮肤进行适当修复。CN201510074653.9公开了一种含富勒烯衍生物的化妆品,其包括服了富勒烯、维生素、多肽、透明质酸钠、胶原蛋白、燕麦多糖、玻尿酸、烟酸胺、甘油,1,3-丙二醇,苯乙基间苯二酚、虾青素等。具有抗衰老,恢复皮肤活力,能够有效降低黑色素生成,促进胶原蛋白合成,也具有抗炎和组织痤疮生成的功效。但是该专利祛斑效果比较差,尤其是炎症所致的色素沉淀。Professor Fathi Moussa has been engaged in the research on the properties of C60 for a long time. As the first person to study dissolving fullerene in olive oil, they fed mice 10-17 months every two weeks (feeding 4 mg richerene per kg body weight) Fullerene), the mice in the control group died within 17-38 months, while the life span of the experimental group was extended to 59-66 months. It was found that fullerene has a longevity health care function. During the period, regardless of body weight, there was no abnormality in physiological performance, and no toxicity or biological heredity of C60 was found. On the contrary, a certain amount of C60 has the ability to scavenge free radicals, thereby protecting animals from the harm of excessive free radicals. Patent 2004800222529 discloses a cosmetic composition containing fullerene clusters. The composition contains fullerene clusters and carriers to prevent or delay the oxidation process of free radicals in the skin. The technical content in this patent does not form protection on the skin surface layer, just to properly repair the skin. CN201510074653.9 discloses a cosmetic containing fullerene derivatives, which includes fullerene, vitamins, polypeptides, sodium hyaluronate, collagen, oat polysaccharide, hyaluronic acid, niacinamide, glycerin, 1,3 - Propylene Glycol, Phenylethyl Resorcinol, Astaxanthin etc. It has anti-aging, restores skin vitality, can effectively reduce melanin production, promote collagen synthesis, and also has anti-inflammatory and anti-acne effects. But this patent freckle effect is relatively poor, especially the pigmentation caused by inflammation.

发明内容Contents of the invention

为了解决上述技术问题,本发明提供一种组合物可彻底解决斑点问题,修复细胞的抗损伤能力,治愈不复发,从根本上解决长斑问题,尤其是炎症所致的色素沉着。In order to solve the above technical problems, the present invention provides a composition that can completely solve the problem of spots, repair the anti-injury ability of cells, cure without recurrence, and fundamentally solve the problem of spots, especially the pigmentation caused by inflammation.

本发明通过下述技术方案实现:The present invention realizes through following technical scheme:

一种美白祛斑组合物,其特征在于,包括下述重量百分比的原料制成:富勒烯0.1-1.2%、乳化剂1-5%、皮肤调理剂3-9%、保湿剂1-20%,余量水。A whitening and spot-removing composition, characterized in that it is made of the following raw materials in weight percentage: 0.1-1.2% of fullerene, 1-5% of emulsifier, 3-9% of skin conditioning agent, and 1-20% of moisturizing agent , the balance of water.

进一步优选,一种美白祛斑组合物,其特征在于,包括下述重量百分比的原料制成:富勒烯0.4-1%、乳化剂2-4%、皮肤调理剂5-8%、保湿剂8-15%,余量水。More preferably, a whitening and freckle-removing composition is characterized in that it is made of the following raw materials in percentage by weight: 0.4-1% of fullerene, 2-4% of emulsifier, 5-8% of skin conditioning agent, and 8% of moisturizing agent -15%, balance water.

更进一步优选,一种美白祛斑组合物,其特征在于,包括下述重量百分比的原料制成:优选富勒烯0.6%、乳化剂3.25%、皮肤调理剂6.4%、保湿剂12%,余量水。More preferably, a whitening and freckle-removing composition is characterized in that it comprises the following raw materials in weight percentage: preferably 0.6% of fullerene, 3.25% of emulsifier, 6.4% of skin conditioner, 12% of moisturizing agent, and the balance water.

本发明所述的祛斑美白组合物中的活动成分是富勒烯具有祛斑美白效果,尤其是对炎症后的色素沉着。人体皮肤接受的氧化应激之后会产生一些炎症因子,炎症因子会激活一些受体,受体激活黑色素细胞产生多过的黑色素。本发明组合物中富勒烯是一个抗氧化抑制炎症因子的作用,抑制氧自由基活性、控制酪胺酸酶氧化;可抑制黑色素细胞产生酪氨酸酶从而形成更多的黑色素。The active ingredient in the freckle-removing and whitening composition of the present invention is fullerene, which has a freckle-removing and whitening effect, especially for post-inflammatory pigmentation. After the oxidative stress received by the human skin, some inflammatory factors will be produced, and the inflammatory factors will activate some receptors, and the receptors activate melanocytes to produce excess melanin. The fullerene in the composition of the present invention has the function of anti-oxidation and inhibition of inflammatory factors, inhibits the activity of oxygen free radicals, controls the oxidation of tyrosinase, and can inhibit the production of tyrosinase by melanocytes to form more melanin.

上述祛斑组合物中,所述富勒烯为空心富勒烯、金属富勒烯、杂环富勒烯和内嵌富勒烯中的一种或几种。包括但不限于富勒烯C2n、M@C2n、M2@C2n、MA@C2n、M3N@C2n、M2C2@C2n、M2S@C2n、M2O@C2n和MxA3-xN@C2n中的任一种,其中,M和A均为金属元素,所述M和A均选自Sc、Y和镧系金属元素中的任意一种;30≤n≤60;0≤x≤3。In the above freckle removing composition, the fullerene is one or more of hollow fullerenes, metal fullerenes, heterocyclic fullerenes and embedded fullerenes. Including but not limited to fullerenes C 2n , M@C 2n , M 2 @C 2n , MA@C 2n , M 3 N@C 2n , M 2 C 2 @C 2n , M 2 S@C 2n , M 2 Any of O@C 2n and M x A 3-x N@C 2n , wherein M and A are metal elements, and the M and A are all selected from any of Sc, Y and lanthanide metal elements a; 30≤n≤60; 0≤x≤3.

进一步优选所述富勒烯选择C60、C70、C76、C84,Gd@C82及其衍生物一种或以上的混合物。It is further preferred that the fullerene is selected from C 60 , C 70 , C 76 , C 84 , Gd@C82 and a mixture of one or more derivatives thereof.

本发明所述的皮肤调理剂是由活性成分富勒烯的复配成分、水溶性油酯、合成油酯、高分子聚合物按照重量比(0.05-0.5):(1-5):(1-5):(0.1-0.5)组成。The skin conditioner of the present invention is composed of the active ingredient fullerene complex, water-soluble oily ester, synthetic oily ester, polymer according to weight ratio (0.05-0.5):(1-5):(1 -5): (0.1-0.5) composition.

进一步优选,所述的皮肤调理剂是由活性物富勒烯的复配成分、水溶性油酯、合成油酯、高分子聚合物按照重量比0.1:3:3:0.3组成。Further preferably, the skin conditioning agent is composed of active fullerene complex components, water-soluble oily esters, synthetic oily esters, and polymers in a weight ratio of 0.1:3:3:0.3.

上述皮肤调理剂中所述活性物的复配成分包括但不限于甘草酸二钾、熊果苷、烟酰胺、抗坏血酸四异棕榈酸酯、传明酸、亚油酸、VC、曲酸、白藜芦醇Rucinol、鞣花酸、香豆酸等,优选甘草酸二钾、烟酰胺、香豆酸,进一步优选甘草酸二钾。所述甘草酸二钾其在本发明组合物中起到阻止组胺的释放,能够加速黑色素代谢,可以抑制黑色素由机理层到表皮层的迁移速率。富勒烯可以抑制诱导黑色素产生的炎症因子,两者复配协同产生美白祛斑的作用且长久不复发。所述烟酰胺能够加速黑色素代谢,可以抑制黑色素由机理层到表皮层的迁移速率,具有与甘草酸二钾相同的效果,与富勒烯复配效果好。The complex ingredients of the active substances in the above skin conditioners include but are not limited to dipotassium glycyrrhizinate, arbutin, niacinamide, ascorbyl tetraisopalmitate, tranexamic acid, linoleic acid, VC, kojic acid, white Rucinol, ellagic acid, coumaric acid, etc., preferably dipotassium glycyrrhizinate, nicotinamide, coumaric acid, more preferably dipotassium glycyrrhizinate. The dipotassium glycyrrhizinate prevents the release of histamine in the composition of the present invention, can accelerate melanin metabolism, and can inhibit the migration rate of melanin from the mechanism layer to the epidermis. Fullerene can inhibit the inflammatory factors that induce melanin production, and the combination of the two synergistically produces the effect of whitening and freckle removal without recurrence for a long time. The nicotinamide can accelerate melanin metabolism, can inhibit the migration rate of melanin from the mechanism layer to the epidermis layer, has the same effect as dipotassium glycyrrhizinate, and has a good compounding effect with fullerene.

上述皮肤调理剂中所述合成油酯包括但不限于液体石蜡、液体矿脂、豆蔻酸异丙酯、棕榈酸异丙酯、棕榈酸2-乙基己基酯、不饱和脂肪酸,如油酸棕榈酸、硬脂酸、山嵛酸、亚油酸、16/18醇中一种或几种。进一步优选合成油脂为16/18醇。本发明所述的16/18醇起到润肤作用,具有良好触感物质,在涂抹后使皮肤呈现光滑,柔软和润滑的感觉。The synthetic oil esters mentioned in the above skin conditioners include but are not limited to liquid paraffin, liquid petrolatum, isopropyl myristate, isopropyl palmitate, 2-ethylhexyl palmitate, unsaturated fatty acids such as palmitate oleate One or more of stearic acid, behenic acid, linoleic acid, and 16/18 alcohol. More preferably, the synthetic fat is 16/18 alcohol. The 16/18 alcohol described in the present invention acts as an emollient, has good touch substances, and makes the skin appear smooth, soft and lubricated after being applied.

上述皮肤调理剂中所述水溶性油酯如水溶性橄榄油酯,米糠油酯,水溶性太阳花籽油,水溶棕榈油酯,水溶性大豆油,水溶性芝麻油,水溶性桃仁油,水溶性玉米油酯,水溶性霍霍巴油酯,水溶性大麻籽油酯,水溶性棉花籽油酯,水溶性椰子油,水溶性巴巴苏油酯,水溶性杏仁油一种或几种的混合物。进一步优选,水溶性橄榄油酯,水溶性霍霍巴油酯,水溶性太阳花籽油脂,水溶性鳄梨油酯,水溶小麦胚牙油酯。本发明所选择的水溶性油脂有良好触感物质,在涂抹后使皮肤呈现光滑,柔软和润滑的感觉。Water-soluble oil esters mentioned in the above skin conditioners such as water-soluble olive oil ester, rice bran oil ester, water-soluble sunflower seed oil, water-soluble palm oil ester, water-soluble soybean oil, water-soluble sesame oil, water-soluble peach kernel oil, water-soluble corn oil Oily esters, water-soluble jojoba oil esters, water-soluble hemp seed oil esters, water-soluble cottonseed oil esters, water-soluble coconut oil, water-soluble babassu oil esters, water-soluble almond oil or a mixture of several. More preferably, water-soluble olive oil esters, water-soluble jojoba oil esters, water-soluble sunflower oil esters, water-soluble avocado oil esters, and water-soluble wheat germ oil esters. The water-soluble oil selected in the present invention has a good touch substance, which makes the skin feel smooth, soft and lubricated after being applied.

上述皮肤调理剂中所述的高分子聚合物为聚季铵盐类,最佳为聚季铵盐-10。聚季铵盐-10(PQ400),中文别名:氯化-2-羟基-3-(三甲氨基)丙基聚环氧乙烷纤维素醚,CAS号:68610-92-4。聚季铵盐-10溶液随着水分挥发,聚季铵盐-10因分子间相互作用而形成网状结构,形成皮膜可保持一定的水分,同时由于成膜性快速吸收的作用。聚季铵盐-10用于皮肤极佳的用后感,提高皮肤抗紫外线能力,优良的保湿滋润性能,还具有抗冲洗能力。The high molecular polymer described in the above skin conditioner is polyquaternium, most preferably polyquaternium-10. Polyquaternium-10 (PQ400), Chinese alias: chloride-2-hydroxy-3-(trimethylamino)propyl polyethylene oxide cellulose ether, CAS number: 68610-92-4. The polyquaternium-10 solution volatilizes with the water, and the polyquaternium-10 forms a network structure due to intermolecular interactions, forming a film that can retain a certain amount of water, and at the same time absorbs quickly due to the film-forming property. Polyquaternium-10 is used for skin with excellent after-use feeling, improves skin's anti-ultraviolet ability, excellent moisturizing performance, and has anti-washing ability.

进一步优选皮肤调理剂包括甘草酸二钾或烟酰胺、16/18醇、水溶性橄榄油酯、聚季铵盐-10按照重量比(0.05-0.5):(1-5):(1-5):(0.1-0.5)组成。更进一步优选皮肤调理剂是由甘草酸二钾、16/18醇、水溶性橄榄油酯、聚季铵盐-10按照重量比0.1:3:3:0.3组成。本发明皮肤调理剂的选择及配比能够很好的协同富勒烯活性成分的美白祛斑效果,尤其是对炎症引起的斑点的消除及改善,祛斑快不反弹,使皮肤润滑细腻。具优异的铺展性、润滑性、滋润型、保湿性和透气性。Further preferred skin conditioners include dipotassium glycyrrhizinate or niacinamide, 16/18 alcohol, water soluble olive oil ester, polyquaternium-10 in weight ratio (0.05-0.5):(1-5):(1-5 ): (0.1-0.5) composition. More preferably, the skin conditioner is composed of dipotassium glycyrrhizinate, 16/18 alcohol, water-soluble olive oil ester, and polyquaternium-10 in a weight ratio of 0.1:3:3:0.3. The selection and proportioning of the skin conditioning agent of the present invention can well cooperate with the whitening and freckle-removing effect of the fullerene active ingredient, especially the elimination and improvement of freckles caused by inflammation, the freckles are quickly removed without rebound, and the skin is lubricated and delicate. It has excellent spreadability, lubricity, moisturization, moisture retention and air permeability.

本发明所述的保湿剂为甘油、丁二醇、聚乙二醇、丙二醇、已二醇、木糖醇、聚丙二醇、山梨糖醇、棕榈酸异丙酯、凡士林、聚二甲基氧硅烷、透明质酸钠中一种或以上。Moisturizing agent of the present invention is glycerin, butylene glycol, polyethylene glycol, propylene glycol, hexylene glycol, xylitol, polypropylene glycol, sorbitol, isopropyl palmitate, vaseline, polydimethyloxysilane 1 or more of sodium hyaluronate.

进一步优选,保湿剂为甘油、凡士林、棕榈酸异丙酯、聚二甲基硅氧烷按照重量份比(2-10):(2-5):(1-5):(1-5)复配。Further preferably, the moisturizing agent is glycerin, vaseline, isopropyl palmitate, and polydimethylsiloxane according to the weight ratio (2-10):(2-5):(1-5):(1-5) compound.

进一步优选,保湿剂为甘油、凡士林、棕榈酸异丙酯、聚二甲基硅氧烷按照重量份比(4-6):(2-4):(1-3):(1-3)复配。Further preferably, the moisturizing agent is glycerin, vaseline, isopropyl palmitate, and polydimethylsiloxane according to the weight ratio (4-6):(2-4):(1-3):(1-3) compound.

更进一步优选,保湿剂为甘油、凡士林、棕榈酸异丙酯、聚二甲基硅氧烷按照重量份比5:3:2:2复配。More preferably, the moisturizing agent is compounded with glycerin, vaseline, isopropyl palmitate, and polydimethylsiloxane in a weight ratio of 5:3:2:2.

本发明的保湿剂,发明人发现在普通大量使用小分子保湿剂如甘油,丙二醇、丁二醇等,它们分子有羟基,使用在皮肤上后,依赖氢键,能够把护肤品里面的水分抓住并停留在皮肤上。此类小分子保湿剂,分子量小,渗透性强,容易进入角质细胞间隙,但是该类小分子保湿剂填加量超过8%时会产生刺激现象,尤其是在化妆品中含有油脂、乳化剂等成分时为了增强保湿性,需要加入大量的小分子成分甘油等,但随之刺激性增强。为了避免强烈的刺激性,在本发明的保湿剂组合中加入了棕榈酸异丙酯、其起到保湿和滋润皮肤的作用,皮肤对本品的吸收性较好,能在皮层内与毛囊有效接触,渗入皮层深处,并将化妆品中的活性组分带入,充分发挥有效成分的作用。凡士林、聚二甲基硅氧烷都起到顺滑肤感。本发明保湿剂的选择与皮肤调理剂中的聚季铵盐的成膜性能够更好的协调保湿作用。For the moisturizer of the present invention, the inventors found that small molecule moisturizers such as glycerin, propylene glycol, butanediol, etc. are commonly used in large quantities. They have hydroxyl groups in their molecules. After being used on the skin, they rely on hydrogen bonds to capture the moisture in skin care products. Lives and stays on skin. This kind of small molecule moisturizer has small molecular weight, strong permeability, and is easy to enter the gap of keratinocytes. However, when the amount of this kind of small molecule moisturizer exceeds 8%, it will cause irritation, especially when cosmetics contain oils, emulsifiers, etc. In order to enhance the moisturizing properties of the ingredients, a large amount of small molecular components such as glycerin need to be added, but the irritation increases accordingly. In order to avoid strong irritation, isopropyl palmitate is added in the moisturizer combination of the present invention, which plays the role of moisturizing and moisturizing the skin. The skin has better absorption of this product and can effectively interact with hair follicles in the cortex. Contact, penetrate deep into the skin layer, and bring in the active ingredients in the cosmetics to give full play to the effect of the active ingredients. Vaseline and Dimethicone both smooth the skin. The selection of the moisturizing agent of the present invention and the film-forming property of the polyquaternium salt in the skin conditioning agent can better coordinate the moisturizing effect.

本发明所述乳化剂,优选十六烷基三甲基氯化铵(1631)、山嵛醇和花生醇葡糖苷(CS200)、聚乙二醇(100)硬脂酸酯和硬脂酸甘油酯(E165)、硬质酸、失水山梨醇倍半油酸酯,聚乙二醇-30,十六烷基三甲基氯化铵,二聚羟基硬脂酸酯,卵磷脂,硬脂酸镁中一种或以上。进一步优选十六烷基三甲基氯化铵、山嵛醇和花生醇葡糖苷、聚乙二醇(100)硬脂酸酯和硬脂酸甘油酯按照重量比(0.1-1):(1-5):(0.5-2)复配。更进一步优选十六烷基三甲基氯化铵、山嵛醇和花生醇葡糖苷、聚乙二醇(100)硬脂酸酯和硬脂酸甘油酯按照重量比0.25:2:1复配。该乳化剂复配可使膏体细腻美观,使用效果最佳。其中十六烷基三甲基氯化铵具有很好的稳定性,抗絮凝剂。The emulsifier of the present invention is preferably cetyltrimethylammonium chloride (1631), behenyl alcohol and arachidyl glucoside (CS200), polyethylene glycol (100) stearate and glyceryl stearate (E165), stearic acid, sorbitan sesquioleate, macrogol-30, cetyltrimethylammonium chloride, dipolyhydroxystearate, lecithin, stearic acid One or more of magnesium. Further preferred cetyl trimethyl ammonium chloride, behenyl alcohol and arachidyl glucoside, polyethylene glycol (100) stearate and glyceryl stearate according to weight ratio (0.1-1): (1- 5): (0.5-2) Compounding. It is further preferred to compound cetyltrimethylammonium chloride, behenyl alcohol and arachidyl glucoside, polyethylene glycol (100) stearate and glyceryl stearate in a weight ratio of 0.25:2:1. The compounding of the emulsifier can make the paste delicate and beautiful, and the use effect is the best. Among them, cetyltrimethylammonium chloride has good stability and is a deflocculant.

作为能够配合的成分,本发明的组合物中还可以加入防腐剂、芳香剂等。As components that can be blended, preservatives, fragrances, and the like can also be added to the composition of the present invention.

优选加入组合物的防腐剂用量0.2-1%,优选0.5-0.8%。所述防腐剂包括水溶性防腐剂、油性防腐剂。优选选择尼泊金甲酯、尼泊金丙酯、苯氧乙醇、乙基己基甘油、叔丁基对苯二酚中一种以上。为了达到较好的防腐杀菌效果,使用一种防腐剂往往严重超出安全使用剂量,带来安全隐患。进一步优选防腐剂选择尼泊金甲酯:尼泊金丙酯:苯氧基乙醇/甲基异噻唑啉酮按照重量份比为(0.5-2):(0.5-2):(2-5)复配。进一步优选,防腐剂选择尼泊金甲酯:尼泊金丙酯:苯氧基乙醇/甲基异噻唑啉酮按照重量份比1.2:1:4复配。本发明复配的防腐剂体系具有协同抗菌作用,在降低各自安全有效使用量前提下,复合使用仍然能保持足够的杀菌能力,且安全无副作用。还能避免二次污染,尤其是对霉菌的杀菌效果,延长了产品的保质期及保证了产品质量。The preservative is preferably added to the composition in an amount of 0.2-1%, preferably 0.5-0.8%. The preservatives include water-soluble preservatives and oily preservatives. Preferably, one or more of methylparaben, propylparaben, phenoxyethanol, ethylhexylglycerin, and tert-butylhydroquinone are selected. In order to achieve a better antiseptic and bactericidal effect, the use of a preservative often seriously exceeds the safe dosage, which brings potential safety hazards. Further preferred preservatives select methylparaben: propylparaben: phenoxyethanol/methylisothiazolinone is (0.5-2): (0.5-2): (2-5) according to the weight ratio compound. Further preferably, the preservative is selected from methylparaben: propylparaben: phenoxyethanol/methylisothiazolinone compounded according to the weight ratio of 1.2:1:4. The compounded preservative system of the present invention has a synergistic antibacterial effect, and under the premise of reducing the safe and effective usage amount of each, it can still maintain sufficient bactericidal ability when used in combination, and is safe and has no side effects. It can also avoid secondary pollution, especially the bactericidal effect on mold, prolong the shelf life of products and ensure product quality.

所述芳香剂用量为0.01-0.05%。The dosage of the aromatic agent is 0.01-0.05%.

本发明所有的保湿剂、皮肤调理剂、乳化剂、防腐剂、芳香剂、活性物均可以市购。All moisturizers, skin conditioners, emulsifiers, preservatives, fragrances, actives of the present invention are commercially available.

有益效果Beneficial effect

1、本发明所述的祛斑美白组合物中的活动成分是富勒烯具有祛斑美白效果,尤其是对炎症后的色素沉着。人体皮肤接受的氧化应激之后会产生一些炎症因子,炎症因子会激活一些受体,受体激活黑色素细胞产生多过的黑色素。本发明组合物中富勒烯是一个抗氧化抑制炎症因子的作用,抑制氧自由基活性、控制酪胺酸酶氧化;可抑制黑色素细胞产生酪氨酸酶从而形成更多的黑色素。所述甘草酸二钾其在本发明组合物中起到阻止组胺的释放,能够加速黑色素代谢,可以抑制黑色素由机理层到表皮层的迁移速率。富勒烯可以抑制诱导黑色素产生的炎症因子,两者复配协同产生美白祛斑的作用且长久不复发。本发明所选择的水溶性油脂有良好触感物质,在涂抹后使皮肤呈现光滑,柔软和润滑的感觉。本发明皮肤调理剂的选择及配比能够很好的协同富勒烯活性成分的美白祛斑效果,尤其是对炎症引起的斑点的消除及改善,祛斑快不复发,使皮肤润滑细腻。具优异的铺展性、润滑性、滋润型、保湿性和透气性。本发明选择的保湿剂与皮肤调理剂中的聚季铵盐的成膜性能够更好的协调保湿作用。各组分复配在一起起到具有快速淡化色斑,还能在一定程度上美白祛斑,祛斑后不复发的作用。本发明所述的斑为黑色素沉着,包括但不限于雀斑、老人斑、黄褐斑、妊娠斑、祛痘、炎症后的色素沉着等。该组合物非常易于透过皮肤角质层,更易于吸收和利用,功效更容易发挥,皮肤润滑细腻。1. The active ingredient in the freckle-removing and whitening composition of the present invention is fullerene, which has a freckle-removing and whitening effect, especially for post-inflammatory pigmentation. After the oxidative stress received by the human skin, some inflammatory factors will be produced, and the inflammatory factors will activate some receptors, and the receptors activate melanocytes to produce excess melanin. The fullerene in the composition of the present invention has the function of anti-oxidation and inhibition of inflammatory factors, inhibits the activity of oxygen free radicals, controls the oxidation of tyrosinase, and can inhibit the production of tyrosinase by melanocytes to form more melanin. The dipotassium glycyrrhizinate prevents the release of histamine in the composition of the present invention, can accelerate melanin metabolism, and can inhibit the migration rate of melanin from the mechanism layer to the epidermis. Fullerene can inhibit the inflammatory factors that induce melanin production, and the combination of the two synergistically produces the effect of whitening and freckle removal without recurrence for a long time. The water-soluble oil selected in the present invention has a good touch substance, which makes the skin feel smooth, soft and lubricated after being applied. The selection and proportioning of the skin conditioning agent of the present invention can well cooperate with the whitening and freckle-removing effects of the fullerene active ingredient, especially for the elimination and improvement of freckles caused by inflammation, and the freckles are quickly removed without recurrence, and the skin is lubricated and delicate. It has excellent spreadability, lubricity, moisturization, moisture retention and air permeability. The film-forming properties of the moisturizing agent selected in the present invention and the polyquaternium salt in the skin conditioning agent can better coordinate the moisturizing effect. The components are compounded together to quickly lighten the spots, and to a certain extent, whiten and remove the spots, without recurring after the spots are removed. The spots described in the present invention are melanosis, including but not limited to freckles, age spots, chloasma, pregnancy spots, acne, post-inflammatory pigmentation and the like. The composition is very easy to penetrate the stratum corneum of the skin, is easier to absorb and utilize, and is easier to exert its efficacy, and the skin is lubricated and delicate.

2、本发明组合物各种黑色素沉着所致的斑均有疗效、治愈率高,且不复发。本发明组合物刺激性小,无副作用,可长期使用。2. The composition of the present invention has curative effect on various spots caused by melanosis, high cure rate, and no recurrence. The composition of the invention has little irritation, no side effect and can be used for a long time.

3、本发明的组合物稳定,存储方便,高低温环境下不分层,不絮凝。3. The composition of the present invention is stable, easy to store, and does not delaminate or flocculate under high and low temperature environments.

4、本发明的组合物细腻,温和、贴肤性强,易于涂抹和吸收。4. The composition of the present invention is delicate, mild, strong skin-adhesive, easy to apply and absorb.

5、本发明配方的复配的防腐体系,广谱抗菌,复配后用量少且安全性提高。5. The antiseptic system compounded by the formula of the present invention has broad-spectrum antibacterial properties, less dosage after compounding and improved safety.

附图说明Description of drawings

附图1本发明组合物的工艺流程图。Accompanying drawing 1 is the process flow chart of composition of the present invention.

具体实施方式Detailed ways

下面对本发明的具体实施方式进行详细描述,但应当理解本发明的保护范围并不受具体实施方式的限制。Specific embodiments of the present invention are described in detail below, but it should be understood that the protection scope of the present invention is not limited by the specific embodiments.

表1实施例1-5Table 1 Example 1-5

制备工艺:在水相锅中投入称好的A相类原料,搅拌加热到85℃,搅拌均匀后加入C相原料,在油相锅中投入称好的B相类原料于85℃完全溶解。将乳化锅预热至60-70℃,抽真空吸入水相及油相,均质(4000r/min)搅拌,冷却至45℃加入D、E,搅拌至均匀后出料。半成品检验合格后灌装,成品检验合格后入库。工艺流程见图1。Preparation process: Put the weighed A phase raw materials into the water phase pot, stir and heat to 85°C, add the C phase raw materials after stirring evenly, put the weighed B phase raw materials into the oil phase pot and dissolve completely at 85°C. Preheat the emulsification pot to 60-70°C, vacuum the water phase and oil phase, stir homogeneously (4000r/min), cool to 45°C, add D and E, stir until uniform, and discharge. Semi-finished products are filled after passing the inspection, and finished products are put into storage after passing the inspection. The process flow is shown in Figure 1.

表2实施例6-10Table 2 Examples 6-10

制备工艺:在水相锅中投入称好的A相类原料,搅拌加热到85℃,搅拌均匀后加入C相原料,在油相锅中投入称好的B相类原料于85℃完全溶解。将乳化锅预热至60-70℃,抽真空吸入水相及油相,均质(4000r/min)搅拌,冷却至45℃加入D、E,搅拌至均匀后出料。半成品检验合格后灌装,成品检验合格后入库。Preparation process: Put the weighed A phase raw materials into the water phase pot, stir and heat to 85°C, add the C phase raw materials after stirring evenly, put the weighed B phase raw materials into the oil phase pot and dissolve completely at 85°C. Preheat the emulsification pot to 60-70°C, vacuum the water phase and oil phase, stir homogeneously (4000r/min), cool to 45°C, add D and E, stir until uniform, and discharge. Semi-finished products are filled after passing the inspection, and finished products are put into storage after passing the inspection.

试验例一:祛斑效果试验Test example 1: Freckle removal effect test

药物:取实施例1的祛斑组合物,Medicine: get the freckle-removing composition of embodiment 1,

遴选40-50岁中年女性50名,进行效果测试。分成五组,每组10人。A-E组。A组:黄褐斑、B组雀斑、C组老人斑、D组妊娠斑、E组痤疮炎症后的色素沉着。每组参加测试的人员反馈效果取平均水平。参加测试的人员,每天使用两次,早晚各一次,取适量涂抹于面部,在斑块处可适当多使用一些产品,并进行适度按摩。测试时间为30天,后续受试者不再使用专业淡斑产品,仅进行常规护肤,继续观察3个月。Select 50 middle-aged women aged 40-50 to conduct effect test. Divide into five groups of 10 people each. Group A-E. Group A: chloasma, group B freckles, group C age spots, group D pregnancy spots, group E pigmentation after acne inflammation. The average level of feedback from each group of people participating in the test was taken. Those who participated in the test used it twice a day, once in the morning and once in the evening, and took an appropriate amount and applied it to the face. They could use some more products on the plaques and massage them moderately. The test time is 30 days, and the follow-up subjects no longer use professional blemish-reducing products, only carry out routine skin care, and continue to observe for 3 months.

表3祛斑效果Table 3 Freckle removal effect

从表3的祛斑效果可见,本发明的组合物具有明显淡斑美白,尤其是炎症所致的斑点效果明显。能够快速祛斑,7天显效,一个月即可完全祛斑,皮肤白净。使用30天后停止使用斑点不会重新出现达到长久不长斑的效果,本产品无依赖性。It can be seen from the freckle removal effect in Table 3 that the composition of the present invention has obvious lightening and whitening effects, especially the freckles caused by inflammation. It can quickly remove freckles, and it will be effective in 7 days, and the freckles can be completely removed in one month, and the skin is fair and clear. After 30 days of use, stop using the spots will not reappear to achieve the effect of long-term no spots, this product has no dependence.

本发明所有实施例及权利要求范围内的组合物都具有同实施例一样的快速祛斑美白,停用不反复的效果。All the compositions within the scope of the embodiments and claims of the present invention have the same rapid freckle-removing and whitening effects as the embodiments, and the effect is not repeated after stopping use.

试验例二,本发明美白祛斑组合物的协同效果Test example two, the synergistic effect of the whitening and spot-removing composition of the present invention

本发明组合物:实施例1Compositions of the invention: Example 1

对比组1:实施例1不含甘草酸二钾的配方Contrast group 1: embodiment 1 does not contain the formula of dipotassium glycyrrhizinate

对比组2:实施例1不含富勒烯的配方Contrast group 2: embodiment 1 does not contain the formula of fullerene

本发明组合物在祛斑后不再复发长斑,肤色日渐莹亮。使用对比组1的受试者,可以达到祛斑效果,但是时间要稍长一些。使用对比组2的受试者,祛斑效果不明显,且停用后,肤色光泽度会反复。The composition of the present invention does not recur freckles after freckle removal, and the skin color becomes brighter and brighter day by day. Using the subjects in the comparison group 1, the freckle removal effect can be achieved, but the time is slightly longer. The subjects who used the comparison group 2 had no obvious freckle removal effect, and after stopping the use, the skin gloss would be repeated.

试验例三、防腐体系的选择试验Test example 3. Selection test of anti-corrosion system

根据美国化妆品,盥洗品和香精联合会(CTFA法)。称取不同防腐体系的产品100g,分别加入灭菌的容器内,各加入1ml金黄色葡糖球菌,大肠杆菌,绿脓杆菌,白色念珠菌,和黑曲霉菌,摇匀。在接菌的第0、7、14、21、28天取样分析。若加菌后7天存活菌量为100CFU/g以下,在28天内全部降至0,视为优秀,通过挑战。如果在7天时存活菌量在1000以下,视为勉强通过,如果在7天时存活菌量在1000以上,视为没有通过防腐挑战,结果见表4According to the Cosmetic, Toiletry and Fragrance Federation (CTFA Act). Weigh 100g of products with different antiseptic systems, add them into sterilized containers, add 1ml each of Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Candida albicans, and Aspergillus niger, and shake well. Samples were taken and analyzed on days 0, 7, 14, 21, and 28 of inoculation. If the amount of surviving bacteria is less than 100CFU/g 7 days after the addition of bacteria, and all drop to 0 within 28 days, it is considered excellent and passed the challenge. If the number of surviving bacteria is less than 1000 at 7 days, it is regarded as barely passing, and if the number of surviving bacteria is more than 1000 at 7 days, it is regarded as failing the antiseptic challenge. The results are shown in Table 4

表4防腐剂选择试验Table 4 Preservative selection test

前述对本发明的具体示例性实施方案的描述是为了说明和例证的目的。这些描述并非想将本发明限定为所公开的精确形式,并且很显然,根据上述教导,可以进行很多改变和变化。对示例性实施例进行选择和描述的目的在于解释本发明的特定原理及其实际应用,从而使得本领域的技术人员能够实现并利用本发明的各种不同的示例性实施方案以及各种不同的选择和改变。本发明的范围意在由权利要求书及其等同形式所限定。The foregoing descriptions of specific exemplary embodiments of the present invention have been presented for purposes of illustration and description. These descriptions are not intended to limit the invention to the precise form disclosed, and obviously many modifications and variations are possible in light of the above teaching. The exemplary embodiments were chosen and described in order to explain the specific principles of the invention and its practical application, thereby enabling others skilled in the art to make and use various exemplary embodiments of the invention, as well as various Choose and change. It is intended that the scope of the invention be defined by the claims and their equivalents.

Claims (10)

1.一种美白祛斑组合物,其特征在于,包括下述重量百分比的原料制成:富勒烯0.1-1.2%、乳化剂1-5%、皮肤调理剂3-9%、保湿剂1-20%,余量水。1. a whitening and spot-removing composition, is characterized in that, comprises the raw material of following percentage by weight to make: fullerene 0.1-1.2%, emulsifier 1-5%, skin conditioning agent 3-9%, humectant 1- 20%, balance water. 2.如权利要求1所述的美白祛斑组合物,其特征在于,包括下述重量百分比的原料制成:富勒烯0.4-1%、乳化剂2-4%、皮肤调理剂5-8%、保湿剂8-15%,余量水。2. The whitening and freckle-removing composition according to claim 1, characterized in that, it comprises the following raw materials in percentage by weight: fullerene 0.4-1%, emulsifier 2-4%, skin conditioning agent 5-8% , Humectant 8-15%, the balance water. 3.如权利要求2所述的美白祛斑组合物,其特征在于,包括下述重量百分比的原料制成:富勒烯0.6%、乳化剂3.25%、皮肤调理剂6.4%、保湿剂12%,余量水。3. The whitening and freckle-removing composition according to claim 2, characterized in that, it comprises the following raw materials in weight percentage: 0.6% of fullerene, 3.25% of emulsifier, 6.4% of skin conditioning agent, 12% of moisturizing agent, Balance water. 4.如权利要求1或3任意一项所述的美白祛斑组合物,其特征在于:所述的保湿剂为甘油、凡士林、棕榈酸异丙酯、聚二甲基硅氧烷按照重量份比(2-10):(2-5):(1-5):(1-5)复配。4. The whitening and freckle-removing composition according to any one of claims 1 and 3, wherein the moisturizing agent is glycerin, petrolatum, isopropyl palmitate, and polydimethylsiloxane according to the weight ratio (2-10):(2-5):(1-5):(1-5) Compounding. 5.如权利要求1或3任意一项所述的美白祛斑组合物,其特征在于:所述乳化剂为十六烷基三甲基氯化铵、山嵛醇和花生醇葡糖苷、聚乙二醇100硬脂酸酯和硬脂酸甘油酯按照重量比(0.1-1):(1-5):(0.5-2)复配。5. The whitening and freckle-removing composition according to any one of claims 1 and 3, wherein the emulsifier is cetyltrimethylammonium chloride, behenyl alcohol and arachidyl glucoside, polyethylene glycol Alcohol 100 stearate and glyceryl stearate are compounded according to the weight ratio (0.1-1):(1-5):(0.5-2). 6.如权利要求1或3任意一项所述的美白祛斑组合物,其特征在于:所述皮肤调理剂是由富勒烯的复配成分、水溶性油酯、合成油酯、高分子聚合物按照重量比(0.05-0.5):(1-5):(1-5):(0.1-0.5)组成。6. The whitening and freckle-removing composition according to any one of claims 1 and 3, characterized in that: the skin conditioner is composed of a compound component of fullerene, water-soluble oily ester, synthetic oily ester, polymer polymer The composition is according to the weight ratio (0.05-0.5):(1-5):(1-5):(0.1-0.5). 7.如权利要求6所述的美白祛斑组合物,其特征在于:所述富勒烯复配成分包括甘草酸二钾、熊果苷、烟酰胺、抗坏血酸四异棕榈酸酯、传明酸、亚油酸、VC、曲酸、白藜芦醇Rucinol、鞣花酸、香豆酸;所述合成油酯包括液体石蜡、液体矿脂、豆蔻酸异丙酯、棕榈酸异丙酯、棕榈酸2-乙基己基酯、不饱和脂肪酸,油酸棕榈酸、硬脂酸、山嵛酸、亚油酸、16/18醇中一种或几种;所述水溶性油酯包括水溶性橄榄油酯,米糠油酯,水溶性太阳花籽油,水溶棕榈油酯,水溶性大豆油,水溶性芝麻油,水溶性桃仁油,水溶性玉米油酯,水溶性霍霍巴油酯,水溶性大麻籽油酯,水溶性棉花籽油酯,水溶性椰子油,水溶性巴巴苏油酯,水溶性杏仁油一种或几种的混合物;所述的高分子聚合物为聚季铵盐类。7. The whitening and freckle-removing composition according to claim 6, characterized in that: the fullerene compound ingredients include dipotassium glycyrrhizinate, arbutin, nicotinamide, ascorbyl tetraisopalmitate, tranexamic acid, Linoleic acid, VC, kojic acid, resveratrol Rucinol, ellagic acid, coumaric acid; the synthetic oil esters include liquid paraffin, liquid petrolatum, isopropyl myristate, isopropyl palmitate, palmitic acid 2-Ethylhexyl ester, unsaturated fatty acid, one or more of oleic palmitic acid, stearic acid, behenic acid, linoleic acid, and 16/18 alcohol; the water-soluble oily ester includes water-soluble olive oil Esters, Rice Bran Oil Esters, Water Soluble Sunflower Seed Oil, Water Soluble Palm Oil Esters, Water Soybean Oil, Water Soluble Sesame Oil, Water Soluble Peach Kernel Oil, Water Soluble Corn Oil Esters, Water Soluble Jojoba Oil Esters, Water Soluble Hemp Seed Oil ester, water-soluble cottonseed oil ester, water-soluble coconut oil, water-soluble babassu oil ester, water-soluble almond oil or a mixture of several kinds; the high molecular polymer is polyquaternium. 8.如权利要求7所述的美白祛斑组合物,其特征在于:所述皮肤调理剂包括甘草酸二钾、16/18醇、水溶性橄榄油酯、聚季铵盐-10按照重量比(0.05-0.5):(1-5):(1-5):(0.1-0.5)复配。8. whitening and speckle-removing composition as claimed in claim 7, is characterized in that: described skin conditioner comprises dipotassium glycyrrhizinate, 16/18 alcohol, water-soluble olive oil ester, polyquaternium-10 according to weight ratio ( 0.05-0.5):(1-5):(1-5):(0.1-0.5) Compounding. 9.如权利要求8所述的美白祛斑组合物,其特征在于,皮肤调理剂包括甘草酸二钾、16/18醇、水溶性橄榄油酯、聚季铵盐-10按照重量比0.1:3:3:0.3复配。9. whitening and speckle-removing composition as claimed in claim 8, is characterized in that, skin conditioner comprises dipotassium glycyrrhizinate, 16/18 alcohol, water-soluble olive oil ester, polyquaternium-10 according to weight ratio 0.1:3 :3:0.3 Compounding. 10.如权利要求1或3任意一项所述的美白祛斑组合物,其特征在于:还包括防腐剂用量为0.2-1%,所述防腐剂为尼泊金甲酯:尼泊金丙酯:苯氧基乙醇/甲基异噻唑啉酮按重量份比为(1-2):(0.5-2):(2-5)复配。10. The whitening and freckle-removing composition according to any one of claims 1 and 3, characterized in that: it also includes a preservative dosage of 0.2-1%, and the preservative is methylparaben: propylparaben : Phenoxyethanol/methylisothiazolinone is (1-2):(0.5-2):(2-5) compounded by weight.
CN201810123967.7A 2018-02-07 2018-02-07 A whitening and freckle-removing composition Active CN108125803B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810123967.7A CN108125803B (en) 2018-02-07 2018-02-07 A whitening and freckle-removing composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810123967.7A CN108125803B (en) 2018-02-07 2018-02-07 A whitening and freckle-removing composition

Publications (2)

Publication Number Publication Date
CN108125803A true CN108125803A (en) 2018-06-08
CN108125803B CN108125803B (en) 2020-11-27

Family

ID=62430601

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810123967.7A Active CN108125803B (en) 2018-02-07 2018-02-07 A whitening and freckle-removing composition

Country Status (1)

Country Link
CN (1) CN108125803B (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108685789A (en) * 2018-07-25 2018-10-23 周恒� A kind of whitening anti-aging smoothing toner and preparation method thereof
CN108714126A (en) * 2018-08-21 2018-10-30 宁波越尚优品贸易有限公司 Skin care compositions and the preparation method and application thereof with moisturizing and anti-oxidation efficacy
CN108852868A (en) * 2018-08-21 2018-11-23 宁波越尚优品贸易有限公司 Composition and the preparation method and application thereof with smoothing wrinkle and senile-resistant efficacy
CN112120954A (en) * 2020-09-09 2020-12-25 浙江大学 Arbutin and coumaric acid zero-order release quaternary compound and preparation method and application thereof
CN112206187A (en) * 2019-07-12 2021-01-12 西安博鸿生物技术有限公司 Skin care compositions
CN113208935A (en) * 2021-05-26 2021-08-06 正定仁运诚医药科技有限责任公司 Cosmetic containing fullerene derivative
CN113440450A (en) * 2021-07-15 2021-09-28 广东雷诺化妆品研究院有限公司 Whitening composition containing fullerene and preparation method and application thereof
US11253443B2 (en) * 2020-01-22 2022-02-22 Max C. Champie Skin products with C60 and niacin
WO2022159332A1 (en) * 2021-01-20 2022-07-28 Sinapu Llc Fullerenic ellagic luteolin and methods
CN115068353A (en) * 2022-05-06 2022-09-20 北京福纳康生物技术有限公司 Fullerene composition, preparation method and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104644467A (en) * 2015-02-12 2015-05-27 安婕妤化妆品科技股份有限公司 Cosmetic containing fullerene derivative
CN106236674A (en) * 2016-09-22 2016-12-21 上海新高姿化妆品有限公司 A kind of compositions with white-skinned face function and the application in cosmetics thereof
KR20170141991A (en) * 2016-06-16 2017-12-27 주식회사 코리아나화장품 Skin protective cosmetic composition for stabilizing vitamin c containing bergenin and fullerene

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104644467A (en) * 2015-02-12 2015-05-27 安婕妤化妆品科技股份有限公司 Cosmetic containing fullerene derivative
KR20170141991A (en) * 2016-06-16 2017-12-27 주식회사 코리아나화장품 Skin protective cosmetic composition for stabilizing vitamin c containing bergenin and fullerene
CN106236674A (en) * 2016-09-22 2016-12-21 上海新高姿化妆品有限公司 A kind of compositions with white-skinned face function and the application in cosmetics thereof

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108685789A (en) * 2018-07-25 2018-10-23 周恒� A kind of whitening anti-aging smoothing toner and preparation method thereof
CN108714126A (en) * 2018-08-21 2018-10-30 宁波越尚优品贸易有限公司 Skin care compositions and the preparation method and application thereof with moisturizing and anti-oxidation efficacy
CN108852868A (en) * 2018-08-21 2018-11-23 宁波越尚优品贸易有限公司 Composition and the preparation method and application thereof with smoothing wrinkle and senile-resistant efficacy
CN108852868B (en) * 2018-08-21 2021-01-15 宁波越尚优品贸易有限公司 Composition with wrinkle removing and anti-aging effects and preparation method and application thereof
CN112206187A (en) * 2019-07-12 2021-01-12 西安博鸿生物技术有限公司 Skin care compositions
CN112206187B (en) * 2019-07-12 2023-03-03 西安博鸿生物技术有限公司 Skin care compositions
US11253443B2 (en) * 2020-01-22 2022-02-22 Max C. Champie Skin products with C60 and niacin
CN112120954A (en) * 2020-09-09 2020-12-25 浙江大学 Arbutin and coumaric acid zero-order release quaternary compound and preparation method and application thereof
CN112120954B (en) * 2020-09-09 2021-08-03 浙江大学 Arbutin and coumaric acid zero-order release quaternary complex and its preparation method and application
WO2022159332A1 (en) * 2021-01-20 2022-07-28 Sinapu Llc Fullerenic ellagic luteolin and methods
CN113208935A (en) * 2021-05-26 2021-08-06 正定仁运诚医药科技有限责任公司 Cosmetic containing fullerene derivative
CN113440450A (en) * 2021-07-15 2021-09-28 广东雷诺化妆品研究院有限公司 Whitening composition containing fullerene and preparation method and application thereof
CN115068353A (en) * 2022-05-06 2022-09-20 北京福纳康生物技术有限公司 Fullerene composition, preparation method and application thereof

Also Published As

Publication number Publication date
CN108125803B (en) 2020-11-27

Similar Documents

Publication Publication Date Title
CN108125803B (en) A whitening and freckle-removing composition
TWI287997B (en) Compositions for retarding skin aging
CA2444282C (en) Preparation for hair and/or scalp
US20090263339A1 (en) Agent for external application to the skin
JPWO2004016236A1 (en) Cosmetics
JP4813690B2 (en) Filaggrin synthesis promoter, stratum corneum moisturizing function improving / enhancing agent and stratum corneum free amino acid content increasing agent
JP2008526963A (en) Compositions and methods for treating overpigmented skin
US11918666B2 (en) Topical formulations comprising strontium and methylsulfonylmethane (MSM) and methods of treatment
JP4414495B2 (en) Antibacterial agent, skin external preparation and skin cleansing agent containing the same
JP5645344B2 (en) External preparation composition
JP2008063295A (en) Skin care preparation containing platinum/silver colloid
KR20110068258A (en) Anti-inflammatory composition
KR101551243B1 (en) Cosmetic Composition for Skin Whitening Having Fomes Fomentarius
JP2001342112A (en) Skin care preparation
KR20130052379A (en) Cosmetics composition for skin lightening color, antioxidantsand and method for preparing the same
CN113197811A (en) Cosmetic with whitening and freckle removing effects and preparation method thereof
JP4906179B2 (en) Topical skin preparation
KR101605324B1 (en) Cosmetic composition for moisturizing skin which alleviates itchiness and dryness by removing keratin and increasing moisture
JP2005008548A (en) External preparation for skin
CN116407486A (en) Active composition, cosmetic composition, application of active composition, repairing essence and preparation method of repairing essence
KR102233709B1 (en) Cosmetic composition containing sulfur and manufacturing method thereof
CN113116753B (en) Rose essential oil face cream and preparation method thereof
KR20150116504A (en) A cosmetics composition containing tea tree and solt
JP4921732B2 (en) Melanin synthesis promoter and topical skin preparation
JP2002370962A (en) Bleaching preparation and cosmetic for preventing and improving aging of skin

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20231108

Address after: 024000 No. 9 Wanze Avenue, Hongshan Economic Development Zone, Chifeng City, Inner Mongolia Autonomous Region

Patentee after: Chifeng Funakang Biotechnology Co.,Ltd.

Address before: 100190 No. 2 North First Street, Haidian District, Beijing, Zhongguancun

Patentee before: INSTITUTE OF CHEMISTRY, CHINESE ACADEMY OF SCIENCES

Patentee before: BEIJING FULLCAN BIOTECHNOLOGY Co.,Ltd.

Effective date of registration: 20231108

Address after: A-205, the second floor of the Art Museum [Suzhou High tech Zone Culture and Sports Center], No. 999, the Taihu Lake Avenue, Technopole, Suzhou Hi tech Zone, Jiangsu 215100

Patentee after: Suzhou Rensheng Zefa Biotechnology Co.,Ltd.

Address before: 024000 No. 9 Wanze Avenue, Hongshan Economic Development Zone, Chifeng City, Inner Mongolia Autonomous Region

Patentee before: Chifeng Funakang Biotechnology Co.,Ltd.

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20231214

Address after: A-205, the second floor of the Art Museum [Suzhou High tech Zone Culture and Sports Center], No. 999, the Taihu Lake Avenue, Technopole, Suzhou Hi tech Zone, Jiangsu 215100

Patentee after: Suzhou Rensheng Zefa Biotechnology Co.,Ltd.

Patentee after: Chifeng Renze Cosmetics Co.,Ltd.

Patentee after: Beijing Rensheng Zefa Biotechnology Co.,Ltd.

Address before: A-205, the second floor of the Art Museum [Suzhou High tech Zone Culture and Sports Center], No. 999, the Taihu Lake Avenue, Technopole, Suzhou Hi tech Zone, Jiangsu 215100

Patentee before: Suzhou Rensheng Zefa Biotechnology Co.,Ltd.

TR01 Transfer of patent right